The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Hermann Lage

Institute of Pathology

Charité Campus Mitte


Name/email consistency: high



  • Institute of Pathology, Charité Campus Mitte. 2010
  • Charité Campus Mitte, Institute of Pathology, Berlin, Germany. 2003 - 2009
  • Humboldt-University Berlin, University Hospital Charité Campus Mitte, Institute of Pathology, Germany. 1999 - 2004
  • Institute of Pathology, Charité Campus Mitte, Humboldt University Berlin, Germany. 1999 - 2001


  1. Bacterial delivery of RNAi effectors: transkingdom RNAi. Lage, H., Krühn, A. J. Vis. Exp (2010) [Pubmed]
  2. Therapeutic potential of RNA interference in drug-resistant cancers. Lage, H. Future. Oncol (2009) [Pubmed]
  3. An overview of cancer multidrug resistance: a still unsolved problem. Lage, H. Cell. Mol. Life Sci. (2008) [Pubmed]
  4. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs. Lage, H., Aki-Sener, E., Yalcin, I. Int. J. Cancer (2006) [Pubmed]
  5. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Lage, H. Curr. Drug. Targets (2006) [Pubmed]
  6. Potential applications of RNA interference technology in the treatment of cancer. Lage, H. Future. Oncology. (london,. England) (2005) [Pubmed]
  7. Proteomics in cancer cell research: an analysis of therapy resistance. Lage, H. Pathol. Res. Pract. (2004) [Pubmed]
  8. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Lage, H. Int. J. Antimicrob. Agents (2003) [Pubmed]
  9. Molecular analysis of therapy resistance in gastric cancer. Lage, H. Dig. Dis (2003) [Pubmed]
  10. Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. Lage, H., Dietel, M. J. Cancer Res. Clin. Oncol. (2002) [Pubmed]
  11. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. Lage, H., Helmbach, H., Grottke, C., Dietel, M., Schadendorf, D. FEBS Lett. (2001) [Pubmed]
  12. Expression of a glypican-related 62-kDa antigen is decreased in hepatocellular carcinoma in correspondence to the grade of tumor differentiation. Lage, H., Kellner, U., Tannapfel, A., Dietel, M. Virchows Arch. (2001) [Pubmed]
  13. Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone. Lage, H., Perlitz, C., Abele, R., Tampé, R., Dietel, M., Schadendorf, D., Sinha, P. FEBS Lett. (2001) [Pubmed]
  14. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells. Lage, H., Jordan, A., Scholz, R., Dietel, M. Int. J. Hyperthermia (2000) [Pubmed]
  15. Effect of the breast-cancer resistance protein on atypical multidrug resistance. Lage, H., Dietel, M. Lancet Oncol. (2000) [Pubmed]
  16. Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. Lage, H., Christmann, M., Kern, M.A., Dietel, M., Pick, M., Kaina, B., Schadendorf, D. Int. J. Cancer (1999) [Pubmed]
  17. Involvement of the DNA mismatch repair system in antineoplastic drug resistance. Lage, H., Dietel, M. J. Cancer Res. Clin. Oncol. (1999) [Pubmed]
WikiGenes - Universities